Autoimmune Hepatitis Treatment: Can Low-Dose Steroids Be Generalized?
Digestive Diseases and Sciences · 2025
DOI: 10.1007/s10620-025-09256-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von Alessandro Granito und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi Hosp…. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Prednisolone, Glucocorticoids. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
We critically examine the implications of Aggarwal et al.'s study on low- versus high-dose prednisolone induction in autoimmune hepatitis (AIH). While acknowledging the study's contribution, this letter argues that the predominantly cirrhotic and often decompensated patient cohort limits the generalizability of its findings to the broader AIH population. We emphasize the potential influence of advanced liver disease on treatment response and side effect profiles, suggesting that similar efficacy between low- and high-dose prednisolone may not extend to all AIH patients. We contend that future research should prioritize more representative AIH cohorts across the spectrum of disease severity to establish universally applicable corticosteroid dosing strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola-Malpighi Hospital, Via Albertoni 15, 40138, Bologna, Italy. alessandro.granito@unib…
- Center for the Study and Treatment of Autoimmune Diseases of the Liver and Biliary System, Department of Medical and Surgical Sciences, University of Bologna, European Reference Network on Hepatological Diseases (ERN RA…
- Division of Internal Medicine, Morgagni-Pierantoni Hospital, 47100, Forlì, Italy.
- Department of Science for the Quality of Life, University of Bologna, Bologna, Italy.
- Mayo Clinic College of Medicine and Science, 200 First Street S.W., Rochester, MN, 55905, USA.
Zitieren
APA
Granito, A., Muratori, P., & Czaja, A. J. (2025). Autoimmune Hepatitis Treatment: Can Low-Dose Steroids Be Generalized?. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-09256-9
Vancouver
Granito A, Muratori P, Czaja AJ. Autoimmune Hepatitis Treatment: Can Low-Dose Steroids Be Generalized?. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-025-09256-9
BibTeX
@article{Granito2025,
author = {Granito, Alessandro and Muratori, Paolo and Czaja, Albert J},
title = {Autoimmune Hepatitis Treatment: Can Low-Dose Steroids Be Generalized?},
journal = {Digestive Diseases and Sciences},
year = {2025},
doi = {10.1007/s10620-025-09256-9}
}
EUVIMED